Found 129 matching trials
Bladder Cancer Adjuvant Radiotherapy Trial
PHASE3Aim and objectives:
This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer
PHASE2This research study is evaluating a drug called enzalutamide in combination...
Location
Hospital Ramón y Cajal
Raltegravir Switch for Toxicity or Adverse Events
PHASE2This study aims to verify the persistent control of the virus replication a...
Location
Policlinico A. Gemelli
Impact of Individual Radiosensitivity on Late Toxicities of Radiosurgery in Essential Trigeminal Neuralgia
NATrigeminal neuralgia is intense, electric-shock-like facial pain, most ofte...
A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
NAThis is a prospective, multicenter, single-arm study designed to verify the...
Location
The Second Affiliated Hospital Of Anhui Medical University
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
PHASE3Trial Title:
FiTNEss (UK-MRA Myeloma XIV) - Frailty-adjusted therapy in Tr...
Location
Aberdeen Royal Infirmary
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
N/AThe incidence rate of colorectal cancer is third in male tumors and second ...
Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Prediction of Chemotherapy Toxicity and Survival in Elderly Cancer Patients by CARG Score
N/APrediction of chemotherapy toxicity and survival in elderly (aged ≥65 years...
Location
Multiple Locations
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
PHASE2RATIONALE: Electronic stimulation using a MC5-A Scrambler may help relieve ...
Location
Multiple Locations
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
PHASE1Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Location
National Institutes of Health Clinical Center